DK1265873T3 - 4-Oxo-1,4-dihydro-3-cinnolincarboxamider som antivirale midler - Google Patents

4-Oxo-1,4-dihydro-3-cinnolincarboxamider som antivirale midler

Info

Publication number
DK1265873T3
DK1265873T3 DK01920138T DK01920138T DK1265873T3 DK 1265873 T3 DK1265873 T3 DK 1265873T3 DK 01920138 T DK01920138 T DK 01920138T DK 01920138 T DK01920138 T DK 01920138T DK 1265873 T3 DK1265873 T3 DK 1265873T3
Authority
DK
Denmark
Prior art keywords
cinnolin
antivirals
carboxamides
dihydro
oxo
Prior art date
Application number
DK01920138T
Other languages
Danish (da)
English (en)
Inventor
Sajiv K Nair
Valerie A Vaillancourt
Scott D Larsen
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK1265873T3 publication Critical patent/DK1265873T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/28Cinnolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK01920138T 2000-03-21 2001-03-15 4-Oxo-1,4-dihydro-3-cinnolincarboxamider som antivirale midler DK1265873T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19129100P 2000-03-21 2000-03-21
PCT/US2001/005811 WO2001070706A2 (en) 2000-03-21 2001-03-15 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents

Publications (1)

Publication Number Publication Date
DK1265873T3 true DK1265873T3 (da) 2004-02-16

Family

ID=22704885

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01920138T DK1265873T3 (da) 2000-03-21 2001-03-15 4-Oxo-1,4-dihydro-3-cinnolincarboxamider som antivirale midler

Country Status (28)

Country Link
US (1) US6624160B2 (zh)
EP (1) EP1265873B1 (zh)
JP (1) JP2003528087A (zh)
KR (1) KR20020081479A (zh)
CN (1) CN1406228A (zh)
AR (1) AR027978A1 (zh)
AT (1) ATE252086T1 (zh)
AU (1) AU2001247224A1 (zh)
BR (1) BR0109487A (zh)
CA (1) CA2400000A1 (zh)
CZ (1) CZ20023141A3 (zh)
DE (1) DE60100999T2 (zh)
DK (1) DK1265873T3 (zh)
EA (1) EA200201002A1 (zh)
EE (1) EE200200541A (zh)
ES (1) ES2208581T3 (zh)
HK (1) HK1052694A1 (zh)
HU (1) HUP0300326A3 (zh)
IL (1) IL151787A0 (zh)
MX (1) MXPA02009251A (zh)
NO (1) NO20024502L (zh)
NZ (1) NZ521524A (zh)
PL (1) PL357443A1 (zh)
PT (1) PT1265873E (zh)
SI (1) SI1265873T1 (zh)
SK (1) SK12102002A3 (zh)
WO (1) WO2001070706A2 (zh)
ZA (1) ZA200207540B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20011349A1 (es) * 2000-06-16 2002-01-19 Upjohn Co 1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales
WO2014070976A1 (en) * 2012-11-03 2014-05-08 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
KR20230170813A (ko) 2018-09-12 2023-12-19 노파르티스 아게 항바이러스 피리도피라진디온 화합물
US11667613B2 (en) 2019-09-26 2023-06-06 Novartis Ag Antiviral pyrazolopyridinone compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8513639D0 (en) 1985-05-30 1985-07-03 Ici America Inc Cinnoline compounds
GB8702288D0 (en) * 1987-02-02 1987-03-11 Erba Farmitalia Cinnoline-carboxamides
ATE239477T1 (de) 1995-08-02 2003-05-15 Darwin Discovery Ltd Chinolone und deren therapeutische verwendung
CA2225555A1 (en) 1995-08-02 1997-02-13 Chiroscience Limited Quinolones and their therapeutic use
NZ505362A (en) 1997-12-22 2004-12-24 Upjohn Co 4-hydroxyquinoline-3-carboxamides and -hydrazides useful as antiviral agents
WO1999038867A1 (fr) 1998-01-29 1999-08-05 Suntory Limited Derives de 1-cycloalkyle-1,8-naphthyridine-4-one presentant une activite inhibitrice de la phosphodiesterase iv

Also Published As

Publication number Publication date
PT1265873E (pt) 2004-03-31
AU2001247224A1 (en) 2001-10-03
CN1406228A (zh) 2003-03-26
WO2001070706A2 (en) 2001-09-27
US20020045619A1 (en) 2002-04-18
ES2208581T3 (es) 2004-06-16
EE200200541A (et) 2004-04-15
CZ20023141A3 (cs) 2003-02-12
NZ521524A (en) 2004-04-30
HUP0300326A3 (en) 2003-09-29
PL357443A1 (en) 2004-07-26
SI1265873T1 (en) 2004-02-29
ZA200207540B (en) 2003-12-19
HUP0300326A2 (hu) 2003-07-28
JP2003528087A (ja) 2003-09-24
US6624160B2 (en) 2003-09-23
EP1265873B1 (en) 2003-10-15
HK1052694A1 (zh) 2003-09-26
DE60100999D1 (en) 2003-11-20
NO20024502L (no) 2002-11-20
WO2001070706A3 (en) 2002-05-10
IL151787A0 (en) 2003-04-10
CA2400000A1 (en) 2001-09-27
SK12102002A3 (sk) 2003-03-04
KR20020081479A (ko) 2002-10-26
ATE252086T1 (de) 2003-11-15
DE60100999T2 (de) 2004-09-02
AR027978A1 (es) 2003-04-23
EA200201002A1 (ru) 2003-02-27
MXPA02009251A (es) 2004-04-05
NO20024502D0 (no) 2002-09-20
BR0109487A (pt) 2003-06-10
EP1265873A2 (en) 2002-12-18

Similar Documents

Publication Publication Date Title
DK1317431T3 (da) Polyarylcarboxamider, der er anvendelige som lipidsænkende midler
NO20043022L (no) 5,6-diaryl-pyrazin-2-amid-derivater som CB1-antagonister
ITTO20010940A0 (it) ,,sedia,,
NL1017075A1 (nl) Preparaat.
DE60214428D1 (de) 1, 4-dihydro-1, 4-diphenylpyridin-derivate
DZ3415A1 (fr) Guanidinobenzamides comme mc4-r agonistes.
NO20034648D0 (no) Hydroksycyklyloksy-, tioksy- og -aminobenzazol-derivater som 5-hydroksytryptamin-6-ligander
FI20000004A0 (fi) Flavonoidilääke...
DE50213548D1 (de) Substituierte 2-carba-3,5-dicyano-4-aryl-6-aminopylektive liganden
NO20025999L (no) Klart, vandig anestetisk preparat
DK1339685T3 (da) Biphenylcarboxamider, der er egnede som lipidsænkende midler
ITTO20010100A0 (it) Macchina di incarto.
ITMI20022335A1 (it) Ugello rotante.
NO20034647L (no) Hydroksyclylalkoksy-, alkyloksy- og -alkylaminobenzazol- derivater som 5-hydroksytryptamin-6-ligander
CH695519A5 (de) Sperrstromthyristor.
DK1265873T3 (da) 4-Oxo-1,4-dihydro-3-cinnolincarboxamider som antivirale midler
BR0210635B1 (pt) produto absorvente.
DK1140851T3 (da) 4-Oxo-1,4-dihydro-3-quinolincarboxamider som antivirale midler
NO20000983L (no) Turwok, sammenleggbar
DE60224192D1 (de) Antihaemorrhagische, betain-enthaltende zusammenseuzungen
ITMI20010486A1 (it) Macchina i.s.
IS7299A (is) 3,4-díhýdró-1H-ísókínólóín-2-ýl-afleiður
ES1046848Y (es) Bombona.
ITBG20000010V0 (it) Flacone ultraplast.
ES1045726Y (es) Conjunto figurativo multiple.